在COPD中吸入类固醇.

Same author

Immunosuppression in Chronic Asthma.

International archives of allergy and immunology·2021

Same author

Serological biomarker screening and host factor analysis elucidating immune response heterogeneity in active pulmonary tuberculosis.

Tropical biomedicine·2021

Same author

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Respiratory medicine·2017

Same author

Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.

COPD·2009

Same author

Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

Respiratory medicine·2009

Same author

Eppur si muove, or COPD treatment success and inflammation.

The European respiratory journal·2007

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

在COPD中吸入类固醇.

相关概念视频

Immunosuppression in Chronic Asthma.

Serological biomarker screening and host factor analysis elucidating immune response heterogeneity in active pulmonary tuberculosis.

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.

Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

Eppur si muove, or COPD treatment success and inflammation.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

在COPD中吸入类固醇.

相关概念视频

相关文章

Immunosuppression in Chronic Asthma.

Serological biomarker screening and host factor analysis elucidating immune response heterogeneity in active pulmonary tuberculosis.

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.

Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

Eppur si muove, or COPD treatment success and inflammation.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.